Balancing transparency and uncertainty

Arch Intern Med. 2012 Jan 9;172(1):74-5. doi: 10.1001/archinternmed.2011.546. Epub 2011 Nov 14.

Authors

Gerald J Dal Pan¹, Robert Temple

Affiliation

¹ Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA. gerald.dalpan@fda.hhs.gov

PMID: 22082709
DOI: 10.1001/archinternmed.2011.546

No abstract available

Publication types

Comment

MeSH terms

Adverse Drug Reaction Reporting Systems / statistics & numerical data*
Patient Safety*